These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2106515)

  • 1. Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment.
    Hollander E; DeCaria CM; Schneier FR; Schneier HA; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1990 Mar; 51(3):119-23. PubMed ID: 2106515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of depersonalization with serotonin reuptake blockers.
    Hollander E; Liebowitz MR; DeCaria C; Fairbanks J; Fallon B; Klein DF
    J Clin Psychopharmacol; 1990 Jun; 10(3):200-3. PubMed ID: 2115893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
    McDougle CJ; Price LH; Goodman WK; Charney DS; Heninger GR
    J Clin Psychopharmacol; 1991 Jun; 11(3):175-84. PubMed ID: 1820757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias.
    Stein DJ; Hollander E; Anthony DT; Schneier FR; Fallon BA; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1992 Aug; 53(8):267-71. PubMed ID: 1386848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obsessive-compulsive disorder.
    March JS; Johnston H; Greist JH
    Am Fam Physician; 1989 May; 39(5):175-82. PubMed ID: 2497627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania.
    Stein DJ; Hollander E
    J Clin Psychiatry; 1992 Apr; 53(4):123-6. PubMed ID: 1532960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG; Thatte S; Wiggins D
    Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of antiobsessional treatment with fenfluramine.
    Hollander E; Liebowitz MR
    Am J Psychiatry; 1988 Oct; 145(10):1314-5. PubMed ID: 3138920
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluvoxamine as an antiobsessional agent.
    Goodman WK; Price LH; Rasmussen SA; Heninger GR; Charney DS
    Psychopharmacol Bull; 1989; 25(1):31-5. PubMed ID: 2505302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypochondriasis and obsessive compulsive disorder: overlaps in diagnosis and treatment.
    Fallon BA; Javitch JA; Hollander E; Liebowitz MR
    J Clin Psychiatry; 1991 Nov; 52(11):457-60. PubMed ID: 1744062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
    Servant D; Bailly D; Le Seac'h H; Parquet PJ
    Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenfluramine augmentation of clomipramine treatment of obsessive compulsive disorder.
    Judd FK; Chua P; Lynch C; Norman T
    Aust N Z J Psychiatry; 1991 Sep; 25(3):412-4. PubMed ID: 1958165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial.
    Liebowitz MR; Hollander E; Schneier F; Campeas R; Hatterer J; Papp L; Fairbanks J; Sandberg D; Davies S; Stein M
    J Clin Psychopharmacol; 1989 Dec; 9(6):423-7. PubMed ID: 2687337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacotherapy of moral or religious scrupulosity.
    Fallon BA; Liebowitz MR; Hollander E; Schneier FR; Campeas RB; Fairbanks J; Papp LA; Hatterer JA; Sandberg D
    J Clin Psychiatry; 1990 Dec; 51(12):517-21. PubMed ID: 2258366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are effective antiobsessional drugs interchangeable?
    Tamimi RR; Mavissakalian MR
    Arch Gen Psychiatry; 1991 Sep; 48(9):857-9. PubMed ID: 1929778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.